← Back to Clinical Trials
Recruiting NCT05790330

Mind and Skin - the Neurocutaneous Axis in Atopic Eczema

Trial Parameters

Condition Atopic Dermatitis
Sponsor King's College London
Study Type OBSERVATIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 12 Years
Max Age 18 Years
Start Date 2023-03-10
Completion 2025-12-01
Interventions
MethotrexateDupilumab

Brief Summary

'Mind and Skin': A prospective cohort study evaluating the impact of inflammation, itch and sleep disturbance on the brain, mental health and cognition, in patients with severe atopy.

Eligibility Criteria

Inclusion Criteria: 1. Patients aged 12 to 18 with atopic eczema (groups 1 and 2), which has been diagnosed by a Consultant Dermatologist. 2. Patients with atopic eczema warranting systemic immuno-modulatory therapy or patients with atopic eczema on topical therapy or healthy controls. 3. Written informed consent for study participation obtained from the patient or from the parent(s) / legal guardian, with assent as determined by the patient's age and level of understanding. 4. Willingness to comply with all study requirements. 5. Competent use of English language, according to patient's age (patients will be required to understand the written questionnaires and complying with instructions during MRI scanning). Exclusion Criteria: 1. Insufficient understanding of the study by the patient and/or parent/guardian. 2. Any clear contra-indication to MRI scanning. In particular this would be due to the presence of any implanted devices or metal from previous surgery or accident. This would b

Related Trials